SS-31 Peptide (Elamipretide): Dosage, Protocol, Reconstitution, and Mitochondrial Health Guide

SS-31 (Elamipretide)

SS-31 is a mitochondria-targeted peptide that binds to cardiolipin in the inner mitochondrial membrane, improving ATP production and reducing oxidative stress. Unlike hormonal peptides, it works directly at the cellular energy level.

How SS-31 Works

Mitochondria Targeting → Cardiolipin Stabilization → ATP ↑ → ROS ↓ → Cellular Energy ↑

SS-31 stabilizes mitochondrial membranes and improves electron transport efficiency. This leads to increased ATP production, reduced oxidative damage, and improved cellular resilience.

SS-31 Protocol

Weeks 1–2

Dose5 mg daily

Units50 units (0.50 mL)

Weeks 3–8

Dose10–20 mg daily

Units100–200 units

Frequency: Once daily
Cycle Length: 4–12 weeks

Real-World vs Clinical Dosing

Low Dose → Mild Effect → Moderate Dose → Strong Effect → High Dose → Full Mitochondrial Support

• 5–10 mg: Entry-level mitochondrial support
• 10–20 mg: Best balance of cost and effectiveness
• 30–40 mg: Clinical-level dosing (strongest outcomes)

Cycle Strategy

• 4–12 week cycles are standard
• Effects may begin within 1–2 weeks
• Longer cycles improve mitochondrial adaptation
• Cycle off due to limited long-term data

When & Where to Inject

• Subcutaneous injection
• Abdomen, thigh, or upper arm
• Rotate injection sites
• Consistent daily timing recommended

Reconstitution & Dosing (10 mg Vial)

Vial 10 mg

Water 1.0 mL bacteriostatic

Concentration 10 mg/mL

Conversion 1 unit = 0.1 mg

Reconstitution Steps

Draw 1.0 mL bacteriostatic water

Inject slowly down vial wall

Gently swirl (do not shake)

Refrigerate immediately

Storage

Lyophilized: −20°C (−4°F)

Reconstituted: 2–8°C (36–46°F)

Use Window

Use within 30 days

Monitoring During Use

• Energy levels and fatigue
• Exercise performance
• Recovery speed
• Cognitive clarity

Benefits

• Improved mitochondrial function
• Increased ATP production
• Reduced oxidative stress
• Enhanced recovery and endurance
• Neuroprotective support
• Cardiometabolic benefits

Potential Side Effects

• Mild injection site irritation
• Temporary redness or itching
• Minimal systemic effects reported
• Limited long-term human data

Stacking Strategies

• Longevity: SS-31 + MOTS-c
• Recovery: SS-31 + BPC-157
• Metabolic: SS-31 + NAD+

Important Disclaimer

SS-31 (Elamipretide) is an investigational peptide and not FDA-approved. This content is for educational purposes only.

Peptide Directory →